Melexis NV (Belgium) Performance
| MELE Stock | EUR 57.50 1.25 2.13% |
Melexis NV has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Melexis NV's returns are expected to increase less than the market. However, during the bear market, the loss of holding Melexis NV is expected to be smaller as well. Melexis NV right now secures a risk of 2.66%. Please verify Melexis NV standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Melexis NV will be following its current price movements.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Melexis NV are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Melexis NV may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Begin Period Cash Flow | 35 M | |
| Free Cash Flow | 148 M |
Melexis |
Melexis NV Relative Risk vs. Return Landscape
If you would invest 5,485 in Melexis NV on December 20, 2024 and sell it today you would earn a total of 265.00 from holding Melexis NV or generate 4.83% return on investment over 90 days. Melexis NV is generating 0.1118% of daily returns and assumes 2.6604% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than Melexis, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Melexis NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Melexis NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Melexis NV, and traders can use it to determine the average amount a Melexis NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.042
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | MELE | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.66 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Melexis NV is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Melexis NV by adding it to a well-diversified portfolio.
Melexis NV Fundamentals Growth
Melexis Stock prices reflect investors' perceptions of the future prospects and financial health of Melexis NV, and Melexis NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Melexis Stock performance.
| Return On Equity | 0.45 | |||
| Return On Asset | 0.27 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 3.37 B | |||
| Shares Outstanding | 40.4 M | |||
| Price To Earning | 25.33 X | |||
| Price To Book | 7.17 X | |||
| Price To Sales | 4.31 X | |||
| Revenue | 836.16 M | |||
| EBITDA | 271.7 M | |||
| Cash And Equivalents | 39.55 M | |||
| Cash Per Share | 0.99 X | |||
| Debt To Equity | 11.60 % | |||
| Book Value Per Share | 11.92 X | |||
| Cash Flow From Operations | 187.84 M | |||
| Earnings Per Share | 4.88 X | |||
| Total Asset | 580.23 M | |||
| Retained Earnings | 275 M | |||
| Current Asset | 223 M | |||
| Current Liabilities | 54 M | |||
About Melexis NV Performance
Assessing Melexis NV's fundamental ratios provides investors with valuable insights into Melexis NV's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Melexis NV is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company was founded in 1988 and is based in Ieper, Belgium. MELEXIS operates under Semiconductor Equipment Materials classification in Belgium and is traded on Brussels Stock Exchange. It employs 1500 people.Things to note about Melexis NV performance evaluation
Checking the ongoing alerts about Melexis NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Melexis NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Melexis NV's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Melexis NV's stock performance include:- Analyzing Melexis NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Melexis NV's stock is overvalued or undervalued compared to its peers.
- Examining Melexis NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Melexis NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Melexis NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Melexis NV's stock. These opinions can provide insight into Melexis NV's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Melexis Stock Analysis
When running Melexis NV's price analysis, check to measure Melexis NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Melexis NV is operating at the current time. Most of Melexis NV's value examination focuses on studying past and present price action to predict the probability of Melexis NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Melexis NV's price. Additionally, you may evaluate how the addition of Melexis NV to your portfolios can decrease your overall portfolio volatility.